Javier José Ordoñez Conrado

Javier José Ordoñez Conrado

Auto-generated profile, based on publicly available information

Javier José Ordoñez Conrado

Universidad Simón Bolívar

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2026 in International Science Journal
Verified
Journal Article
Open access
PDF file
JCJavier Emanuel Camacho-Patiño
Javier Emanuel Camacho-Patiño
GLGuillermo Andres Díaz León
Guillermo Andres Díaz León
LPLuis Felipe Espinal Pérez
Luis Felipe Espinal Pérez
KCKatherine Paola Hidalgo Chuquimarca
Katherine Paola Hidalgo Chuquimarca
ERErika Romina Cuenca Riascos
Erika Romina Cuenca Riascos
JCJavier José Ordoñez Conrado
Javier José Ordoñez Conrado
The menopausal transition is associated with significant endocrine, epithelial, and immunological changes that influence vulvar health and may complicate the recognition of inflammatory and autoimmune dermatological disorders. This narrative review aimed to analyze the relationship between menopausal hormonal alterations and vulvar dermatoses, emphasizing pathophysiological mechanisms, clinical manifestations, differential diagnosis, and evidence-based therapeutic strategies. A qualitative synthesis of 20 scientific publications was conducted, incorporating international clinical research, epidemiological investigations, reviews, and professional guidelines, including evidence from Latin America. The findings identified estrogen deficiency as an important contributor to epithelial fragility, reduced lubrication, altered vaginal microbiota, and genitourinary syndrome of menopause. However, these alterations frequently coexist with independent conditions, including lichen sclerosus, erosive lichen planus, contact dermatitis, lichen simplex chronicus, and genital psoriasis. Considerable overlap was observed in symptoms such as pruritus, burning, dryness, and dyspareunia, whereas characteristic morphological findings provided greater diagnostic differentiation. Epidemiological evidence demonstrated substantial variability in the reported prevalence of menopausal genitourinary symptoms, with relevant findings from a Brazilian population-based study. Therapeutic approaches differed according to the underlying condition, with local hormonal treatments and nonhormonal interventions primarily indicated for genitourinary syndrome of menopause, while topical anti-inflammatory agents remained central to the management of inflammatory dermatoses. The available evidence also highlighted uncertainties surrounding emerging therapeutic technologies and the limited representation of Latin American populations. In conclusion, vulvar disorders during the menopausal transition require comprehensive evaluation that distinguishes hormonal tissue changes from independent inflammatory diseases. An integrated dermatological, gynecological, and endocrinological approach is essential for accurate diagnosis, individualized treatment, and appropriate long-term clinical surveillance.

30 June 2026 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
JCJosé Arnulfo Pérez Carrillo
José Arnulfo Pérez Carrillo
JCJavier José Ordoñez Conrado
Javier José Ordoñez Conrado
KJKeren Abigail Saynes Jarquin
Keren Abigail Saynes Jarquin
BABricey Daniela Fonseca Aldana
Bricey Daniela Fonseca Aldana
KSKarena Espinoza Saavedra
Karena Espinoza Saavedra
FCFabio Camilo Jaramillo Contreras
Fabio Camilo Jaramillo Contreras
Abdominal extranodal lymphomas represent a heterogeneous group of hematological malignancies characterized by diverse anatomical presentations, histopathological features, and molecular abnormalities that complicate accurate diagnosis and therapeutic selection. This narrative review examines the diagnostic relevance of surgical biopsy, immunophenotypic profiling, and comprehensive histopathological characterization in the classification and personalized management of these neoplasms. International scientific literature, including contributions from Latin American research groups, was analyzed to examine tissue acquisition strategies, diagnostic classifications, immunohistochemical markers, molecular investigations, and subtype-specific therapeutic approaches. The reviewed evidence indicates that adequate tissue sampling is essential for definitive lymphoma subclassification, particularly when morphological architecture and ancillary studies are required. Laparoscopic biopsy may provide greater specimen adequacy than percutaneous techniques in selected cases, although procedural selection should consider anatomical accessibility, clinical conditions, and diagnostic requirements. Immunophenotypic and molecular characterization allows differentiation among diffuse large B-cell lymphoma, extranodal marginal zone lymphoma, mantle cell lymphoma, follicular lymphoma, and intestinal T-cell lymphomas, each exhibiting distinct biological and therapeutic characteristics. These diagnostic differences influence the selection of systemic immunochemotherapy, targeted interventions, infection-directed treatment, and surgical management when clinically indicated. Evidence from Mexico, Peru, and Brazil contributes regional perspectives on biopsy performance and lymphoma characterization, although further multicenter investigations remain necessary. Overall, the findings support an integrated multidisciplinary approach in which appropriate tissue acquisition and precise pathological classification constitute essential foundations for personalized treatment and improved diagnostic decision-making in abdominal extranodal lymphomas.

30 June 2026 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
EMEduardo Tadeo Hernández Monreal
Eduardo Tadeo Hernández Monreal
AMAnthony Fabián Gallardo Martínez
Anthony Fabián Gallardo Martínez
FHFrida Desiree Lara Hernández
Frida Desiree Lara Hernández
KCKatherine Paola Hidalgo Chuquimarca
Katherine Paola Hidalgo Chuquimarca
ERErika Romina Cuenca Riascos
Erika Romina Cuenca Riascos
PMPablo David Izquierdo Medina
Pablo David Izquierdo Medina
Hemorrhagic brain metastases represent a major challenge in contemporary neuro-oncology due to their association with acute neurological deterioration, intracranial hypertension, functional impairment, and complex therapeutic decision-making. Their clinical behavior is influenced by primary tumor histology, vascular abnormalities, metastatic lesion characteristics, coagulation disturbances, and previous oncological treatments. This narrative review aimed to critically examine the determinants of intracranial bleeding, neurosurgical indications, and multimodal treatment strategies in adults with hemorrhagic brain metastases. Relevant international scientific literature, including observational cohorts, randomized clinical trials, and multidisciplinary guidelines, was analyzed through a descriptive and integrative approach, incorporating contributions from Latin America. The reviewed evidence identified melanoma, renal cell carcinoma, and thyroid carcinoma as malignancies with substantial hemorrhagic susceptibility. Tumor dimensions and pre-existing bleeding were associated with differences in hemorrhagic presentation and local disease control. Observational studies evaluating therapeutic anticoagulation did not demonstrate a uniform increase in intracranial bleeding, although important limitations remain in patients with active hemorrhage. Neurosurgical resection provides established benefits in selected patients with brain metastases, particularly regarding local control and neurological outcomes, but evidence specifically addressing hemorrhagic lesions remains limited. Stereotactic radiosurgery offers an important local treatment option, although hemorrhagic metastases may exhibit inferior local control compared with nonhemorrhagic lesions. Immunotherapy and molecularly targeted treatments have expanded therapeutic possibilities, yet their optimal integration in acute hemorrhagic presentations remains uncertain. Overall, the findings emphasize that hemorrhagic status alone should not determine treatment selection. Individualized multidisciplinary assessment incorporating neurological severity, tumor biology, hematological risk, and systemic oncological prognosis is essential. Further prospective multicenter investigations are necessary to establish standardized risk stratification and optimize therapeutic sequencing.

30 June 2026 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
CAChristian Jason Ortiz Alvarez
Christian Jason Ortiz Alvarez
OAOmar Abdel Orellana Arévalo
Omar Abdel Orellana Arévalo
JCJavier José Ordoñez Conrado
Javier José Ordoñez Conrado
TSTatiana Isabel Panqueva Sánchez
Tatiana Isabel Panqueva Sánchez
FCFabio Camilo Jaramillo Contreras
Fabio Camilo Jaramillo Contreras
KSKarena Espinoza Saavedra
Karena Espinoza Saavedra
Long-duration spaceflight exposes astronauts to environmental and physiological conditions that challenge circadian synchronization, sleep regulation, and cardiovascular homeostasis. Understanding the interactions among these processes is essential for preserving physiological performance and operational safety during future lunar and interplanetary missions. This narrative review aimed to examine the relationship between circadian disruption, sleep disturbances, and cardiovascular adaptation during prolonged exposure to microgravity, while evaluating the available evidence concerning preventive countermeasures. Scientific literature addressing aerospace physiology, chronobiology, sleep medicine, and cardiovascular regulation was critically synthesized, with particular emphasis on observational studies involving astronauts, physiological investigations, and specialized reviews. The findings revealed persistent sleep restriction during orbital missions, with reported mean sleep durations of approximately six hours per night. Changes in cardiovascular autonomic regulation were documented through alterations in heart rate variability, including modifications in fractal scaling and spectral power. Hemodynamic investigations demonstrated reductions in arterial pressure and systemic vascular resistance, accompanied by increases in cardiac output and stroke volume during prolonged microgravity exposure. Although these findings indicate substantial physiological adaptation, the independent contribution of circadian misalignment to cardiovascular deconditioning remains uncertain. Countermeasures involving controlled lighting, structured sleep schedules, exercise training, and mechanical loading address different physiological demands, but their combined effectiveness has not been adequately established. The available evidence is limited by small astronaut populations, methodological heterogeneity, and insufficient simultaneous monitoring of circadian and cardiovascular parameters. An integrated approach combining biological rhythm assessment, cardiovascular monitoring, and individualized preventive interventions may improve the characterization of physiological adaptation during extended missions. Further longitudinal investigations are required to clarify causal mechanisms and establish effective strategies for maintaining astronaut health during sustained human exploration beyond Earth.